TrialJACC. Heart failure2016

Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction.

John J Lepore et al.PubMed ↗Publisher ↗

No numbers read from the abstract.